| Year |
Citation |
Score |
| 2023 |
Corlis J, Zhu J, Macul H, Tiberi O, Boothe MAS, Resch SC. Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis-with an illustrative case of HIV treatment in Mozambique. Cost Effectiveness and Resource Allocation : C/E. 21: 62. PMID 37705101 DOI: 10.1186/s12962-023-00474-4 |
0.372 |
|
| 2023 |
Bollinger LA, Corlis J, Ombam R, Forsythe S, Resch SC. Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned. Bmc Public Health. 23: 1055. PMID 37264335 DOI: 10.1186/s12889-023-15964-6 |
0.357 |
|
| 2022 |
Resch SC, Foote JHA, Wirth KE, Lasry A, Scott JA, Moore J, Shebl FM, Gaolathe T, Feser MK, Lebelonyane R, Hyle EP, Mmalane MO, Bachanas P, Yu L, Makhema JM, et al. Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 35420554 DOI: 10.1097/QAI.0000000000002996 |
0.313 |
|
| 2021 |
Murphy JP, Kgowedi S, Naidoo N, Girdwood S, Jamieson L, Soeteman D, Resch S, Meyer-Rath G. Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa. Health Policy and Planning. 36: 1545-1551. PMID 34212192 DOI: 10.1093/heapol/czab071 |
0.309 |
|
| 2021 |
Chatterjee S, Das P, Pinheiro A, Haldar P, Ray A, Brenzel L, Resch S. The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme. Health Policy and Planning. PMID 33950262 DOI: 10.1093/heapol/czab053 |
0.333 |
|
| 2020 |
Neilan AM, Bulteel AJB, Hosek SG, Foote JHA, Freedberg KA, Landovitz RJ, Walensky RP, Resch SC, Kazemian P, Paltiel AD, Weinstein MC, Wilson CM, Ciaranello AL. Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32730625 DOI: 10.1093/Cid/Ciaa1061 |
0.532 |
|
| 2020 |
Portnoy A, Vaughan K, Clarke-Deelder E, Suharlim C, Resch SC, Brenzel L, Menzies NA. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. Pharmacoeconomics. PMID 32596785 DOI: 10.1007/S40273-020-00930-6 |
0.418 |
|
| 2020 |
Soeteman DI, Resch SC, Jalal H, Dugdale CM, Penazzato M, Weinstein MC, Phillips A, Hou T, Abrams EJ, Dunning L, Newell ML, Pei PP, Freedberg KA, Walensky RP, Ciaranello AL. Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers. Mdm Policy & Practice. 5: 2381468320932894. PMID 32587893 DOI: 10.1177/2381468320932894 |
0.488 |
|
| 2020 |
Kazemian P, Costantini S, Neilan AM, Resch SC, Walensky RP, Weinstein MC, Freedberg KA. A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease. Journal of Biomedical Informatics. 103475. PMID 32526280 DOI: 10.1016/J.Jbi.2020.103475 |
0.527 |
|
| 2020 |
Resch S, Guha M, Ward Z, Suarez Zarate S, Borovac-Pinheiro A, Omotayo M, Garg L, Hansel S, Burke T. Cost-effectiveness of postpartum haemorrhage first response bundle and non-surgical interventions for refractory postpartum haemorrhage in India: an ex-ante modelling study The Lancet Global Health. 8: S42. DOI: 10.1016/S2214-109X(20)30183-2 |
0.398 |
|
| 2019 |
Munk C, Portnoy A, Suharlim C, Clarke-Deelder E, Brenzel L, Resch SC, Menzies NA. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries. Bmc Health Services Research. 19: 741. PMID 31640687 DOI: 10.1186/S12913-019-4468-4 |
0.42 |
|
| 2019 |
Lee DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, Mayer KH, Tripathy S, Paltiel AD, Freedberg KA, Reddy KP. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector. Plos One. 14: e0218890. PMID 31265470 DOI: 10.1371/Journal.Pone.0218890 |
0.312 |
|
| 2019 |
Feldhaus I, Schütte C, Mwansa FD, Undi M, Banda S, Suharlim C, Menzies NA, Brenzel L, Resch SC, Kinghorn A. Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study. Health Policy and Planning. PMID 31157376 DOI: 10.1093/Heapol/Czz039 |
0.371 |
|
| 2019 |
Rivera-Rodriguez C, Toscano C, Resch S. Improved calibration estimators for the total cost of health programs and application to immunization in Brazil. Plos One. 14: e0212401. PMID 30840645 DOI: 10.1371/Journal.Pone.0212401 |
0.43 |
|
| 2019 |
Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, et al. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. The Lancet. Global Health. 7: e200-e208. PMID 30683239 DOI: 10.1016/S2214-109X(18)30436-4 |
0.399 |
|
| 2019 |
Resch S, Hecht R. Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research. Journal of Global Health. 8: 010301. PMID 29391944 DOI: 10.7189/Jogh.08.010301 |
0.307 |
|
| 2018 |
Chang AY, Riumallo-Herl C, Salomon JA, Resch SC, Brenzel L, Verguet S. Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries. Bmc Medicine. 16: 102. PMID 29970074 DOI: 10.1186/S12916-018-1074-Y |
0.36 |
|
| 2018 |
Rivera-Rodriguez CL, Resch S, Haneuse S. Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries. Sage Open Medicine. 6: 2050312118765602. PMID 29636964 DOI: 10.1177/2050312118765602 |
0.417 |
|
| 2018 |
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy and Planning. PMID 29529282 DOI: 10.1093/Heapol/Czy018 |
0.364 |
|
| 2018 |
Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, Kristiansen PA, LaForce FM, Cohen T. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. Plos Medicine. 15: e1002495. PMID 29364884 DOI: 10.1371/Journal.Pmed.1002495 |
0.353 |
|
| 2018 |
Lee DJ, Kumarasamy N, Resch S, Sivaramakrishnan GN, Mayer K, Tripathy S, Paltiel AD, Freedberg K, Reddy KP. 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector Open Forum Infectious Diseases. 5: S582-S582. DOI: 10.1093/Ofid/Ofy210.1656 |
0.361 |
|
| 2017 |
Sharifi M, Franz C, Horan CM, Giles CM, Long MW, Ward ZJ, Resch SC, Marshall R, Gortmaker SL, Taveras EM. Cost-Effectiveness of a Clinical Childhood Obesity Intervention. Pediatrics. 140. PMID 29089403 DOI: 10.1542/Peds.2016-2998 |
0.349 |
|
| 2017 |
Menzies NA, Suharlim C, Geng F, Ward ZJ, Brenzel L, Resch SC. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies. Bmc Medicine. 15: 178. PMID 28982358 DOI: 10.1186/S12916-017-0942-1 |
0.369 |
|
| 2017 |
Hyle EP, Jani IV, Rosettie KL, Wood R, Osher B, Resch S, Pei PP, Maggiore P, Freedberg KA, Peter T, Parker RA, Walensky RP. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. Aids (London, England). 31: 2135-2145. PMID 28906279 DOI: 10.1097/Qad.0000000000001586 |
0.308 |
|
| 2017 |
Campos NG, Sharma M, Clark A, Lee K, Geng F, Regan C, Kim J, Resch S. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 138: 47-56. PMID 28691334 DOI: 10.1002/Ijgo.12184 |
0.367 |
|
| 2017 |
Geng F, Suharlim C, Brenzel L, Resch SC, Menzies NA. The cost structure of routine infant immunization services: a systematic analysis of six countries. Health Policy and Planning. PMID 28575193 DOI: 10.1093/Heapol/Czx067 |
0.387 |
|
| 2017 |
Juneja S, Gupta A, Moon S, Resch S. Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP). Plos One. 12: e0177770. PMID 28542239 DOI: 10.1371/Journal.Pone.0177770 |
0.46 |
|
| 2017 |
Chang AY, Robinson LA, Hammitt JK, Resch SC. Economics in "Global Health 2035": a sensitivity analysis of the value of a life year estimates. Journal of Global Health. 7: 010401. PMID 28400950 DOI: 10.7189/Jogh.07.010401 |
0.312 |
|
| 2017 |
Korenromp EL, Wi T, Resch S, Stover J, Broutet N. Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021. Plos One. 12: e0170773. PMID 28129372 DOI: 10.1371/Journal.Pone.0170773 |
0.391 |
|
| 2017 |
Chang AY, Riumallo-Herl C, Resch SC, Verguet S. Estimation of distribution of childhood diarrhoea, measles, and pneumonia morbidity and mortality by socio-economic group in low-income and middle-income countries The Lancet Global Health. 5: S15. DOI: 10.1016/S2214-109X(17)30122-5 |
0.341 |
|
| 2016 |
Cradock AL, Barrett JL, Kenney EL, Giles CM, Ward ZJ, Long MW, Resch SC, Pipito AA, Wei ER, Gortmaker SL. Using cost-effectiveness analysis to prioritize policy and programmatic approaches to physical activity promotion and obesity prevention in childhood. Preventive Medicine. PMID 27773710 DOI: 10.1016/J.Ypmed.2016.10.017 |
0.371 |
|
| 2016 |
Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries. Plos One. 11: e0164000. PMID 27711124 DOI: 10.1371/Journal.Pone.0164000 |
0.306 |
|
| 2016 |
Robinson LA, Hammitt JK, Chang AY, Resch S. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds. Health Policy and Planning. PMID 27452949 DOI: 10.1093/Heapol/Czw096 |
0.435 |
|
| 2016 |
Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Annals of Internal Medicine. PMID 27240120 DOI: 10.7326/M16-0799 |
0.526 |
|
| 2016 |
Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, Bärnighausen T. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. Bmj Open. 6: e009656. PMID 26948960 DOI: 10.1136/Bmjopen-2015-009656 |
0.42 |
|
| 2015 |
Walensky RP, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel AD. Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection. The Journal of Infectious Diseases. PMID 26681778 DOI: 10.1093/Infdis/Jiv523 |
0.376 |
|
| 2015 |
Gortmaker SL, Wang YC, Long MW, Giles CM, Ward ZJ, Barrett JL, Kenney EL, Sonneville KR, Afzal AS, Resch SC, Cradock AL. Three Interventions That Reduce Childhood Obesity Are Projected To Save More Than They Cost To Implement. Health Affairs (Project Hope). 34: 1932-9. PMID 26526252 DOI: 10.1377/Hlthaff.2015.0631 |
0.361 |
|
| 2015 |
Jiang Y, Resch S, Liu X, Rogers SO, Askari R, Klompas M, Jayaraman SP. The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients. Surgical Infections. PMID 26356287 DOI: 10.1089/Sur.2015.036 |
0.338 |
|
| 2015 |
Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M, et al. Defeating AIDS-advancing global health. Lancet (London, England). PMID 26117719 DOI: 10.1016/S0140-6736(15)60658-4 |
0.397 |
|
| 2015 |
Wright DR, Kenney EL, Giles CM, Long MW, Ward ZJ, Resch SC, Moodie ML, Carter RC, Wang YC, Sacks G, Swinburn BA, Gortmaker SL, Cradock AL. Modeling the Cost Effectiveness of Child Care Policy Changes in the U.S. American Journal of Preventive Medicine. 49: 135-47. PMID 26094234 DOI: 10.1016/J.Amepre.2015.03.016 |
0.341 |
|
| 2015 |
Long MW, Gortmaker SL, Ward ZJ, Resch SC, Moodie ML, Sacks G, Swinburn BA, Carter RC, Claire Wang Y. Cost Effectiveness of a Sugar-Sweetened Beverage Excise Tax in the U.S. American Journal of Preventive Medicine. 49: 112-23. PMID 26094232 DOI: 10.1016/J.Amepre.2015.03.004 |
0.368 |
|
| 2015 |
Gortmaker SL, Long MW, Resch SC, Ward ZJ, Cradock AL, Barrett JL, Wright DR, Sonneville KR, Giles CM, Carter RC, Moodie ML, Sacks G, Swinburn BA, Hsiao A, Vine S, et al. Cost Effectiveness of Childhood Obesity Interventions: Evidence and Methods for CHOICES. American Journal of Preventive Medicine. 49: 102-11. PMID 26094231 DOI: 10.1016/J.Amepre.2015.03.032 |
0.332 |
|
| 2015 |
Hackenberg B, Ramos MS, Campbell A, Resch S, Finlayson SR, Sarma H, Howaldt HP, Caterson EJ. Measuring and Comparing the Cost-Effectiveness of Surgical Care Delivery in Low-Resource Settings: Cleft Lip and Palate as a Model. The Journal of Craniofacial Surgery. 26: 1121-5. PMID 26080139 DOI: 10.1097/Scs.0000000000001829 |
0.386 |
|
| 2015 |
Valdés W, Janusz CB, Molina Aguilera IB, Mendoza L, Díaz IY, Resch S. Tracking financial flows for immunization in Honduras. Vaccine. 33: A85-92. PMID 25919182 DOI: 10.1016/J.Vaccine.2015.01.012 |
0.361 |
|
| 2015 |
Janusz CB, Castañeda-Orjuela C, Molina Aguilera IB, Felix Garcia AG, Mendoza L, Díaz IY, Resch SC. Examining the cost of delivering routine immunization in Honduras. Vaccine. 33: A53-9. PMID 25919175 DOI: 10.1016/J.Vaccine.2015.01.016 |
0.38 |
|
| 2015 |
Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions. Vaccine. 33: A21-7. PMID 25919164 DOI: 10.1016/J.Vaccine.2014.12.080 |
0.33 |
|
| 2015 |
Novaes HM, de Soárez PC, Silva GA, Ayres A, Itria A, Rama CH, Sartori AM, Clark AD, Resch S. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine. 33: A135-42. PMID 25919154 DOI: 10.1016/J.Vaccine.2014.12.031 |
0.357 |
|
| 2015 |
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: An analysis of domestic spending in 12 low-income and middle-income countries The Lancet Global Health. 3: e52-e61. PMID 25539970 DOI: 10.1016/S2214-109X(14)70342-0 |
0.389 |
|
| 2014 |
Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RP. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. Plos Medicine. 11: e1001725. PMID 25225800 DOI: 10.1371/Journal.Pmed.1001725 |
0.312 |
|
| 2014 |
Chao TE, Sharma K, Mandigo M, Hagander L, Resch SC, Weiser TG, Meara JG. Cost-effectiveness of surgery and its policy implications for global health: a systematic review and analysis. The Lancet. Global Health. 2: e334-45. PMID 25103302 DOI: 10.1016/S2214-109X(14)70213-X |
0.359 |
|
| 2014 |
Doherty K, Essajee S, Penazzato M, Holmes C, Resch S, Ciaranello A. Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations. Bmc Health Services Research. 14: 201. PMID 24885453 DOI: 10.1186/1472-6963-14-201 |
0.41 |
|
| 2014 |
Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM. Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. Journal of Thrombosis and Haemostasis : Jth. 11: 1032-42. PMID 23452204 DOI: 10.1111/Jth.12184 |
0.311 |
|
| 2014 |
Novaes HMD, e Silva GA, Itria A, Rama CH, Sartori AM, de Soárez PC, Clark A, Resch S. Introduction of universal human papillomavirus vaccination of girls aged 11 years to the National Immunization Program in Brazil: a cost-effectiveness analysis The Lancet. 384: S19. DOI: 10.1016/S0140-6736(14)61882-1 |
0.442 |
|
| 2013 |
Castañeda-Orjuela C, Romero M, Arce P, Resch S, Janusz CB, Toscano CM, De la Hoz-Restrepo F. Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization. Vaccine. 31: C72-9. PMID 23777695 DOI: 10.1016/J.Vaccine.2013.05.038 |
0.429 |
|
| 2013 |
Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S, Ruiz Matus C, Andrus JK. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience. Vaccine. 31: C12-8. PMID 23777685 DOI: 10.1016/J.Vaccine.2013.05.033 |
0.32 |
|
| 2013 |
Chen SC, Toy M, Yeh JM, Wang JD, Resch S. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics. 131: e1135-43. PMID 23530168 DOI: 10.1542/Peds.2012-1262 |
0.315 |
|
| 2013 |
Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts. Bmc Medicine. 11: 23. PMID 23363734 DOI: 10.1186/1741-7015-11-23 |
0.387 |
|
| 2013 |
Spaulding AC, Pinkerton SD, Superak H, Cunningham MJ, Resch S, Jordan AO, Yang Z. Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention. Aids and Behavior. 17: S220-6. PMID 23138877 DOI: 10.1007/S10461-012-0353-4 |
0.454 |
|
| 2013 |
Novaes H, azevedo e Silva G, Ayres A, Itria A, Rama C, Sartori A, De Soarez P, Clark A, Resch S. Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil Value in Health. 16: A685. DOI: 10.1016/J.Jval.2013.08.2031 |
0.343 |
|
| 2012 |
Janusz CB, Jauregui B, Sinha A, Clark AD, Bolaños BM, Resch S, Toscano C, Andrus JK. Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean. Value in Health Regional Issues. 1: 248-253. PMID 29702908 DOI: 10.1016/j.vhri.2012.10.003 |
0.309 |
|
| 2012 |
Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MC. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Effectiveness and Resource Allocation : C/E. 10: 12. PMID 22992315 DOI: 10.1186/1478-7547-10-12 |
0.684 |
|
| 2012 |
Erim DO, Resch SC, Goldie SJ. Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria. Bmc Public Health. 12: 786. PMID 22978519 DOI: 10.1186/1471-2458-12-786 |
0.32 |
|
| 2012 |
Lin MM, Goldsmith JD, Resch SC, DeAngelis JP, Ramappa AJ. Histologic examinations of arthroplasty specimens are not cost-effective: a retrospective cohort study. Clinical Orthopaedics and Related Research. 470: 1452-60. PMID 22057818 DOI: 10.1007/S11999-011-2149-7 |
0.357 |
|
| 2012 |
Janusz CB, Jauregui B, Sinha A, Clark AD, Bolaños BM, Resch S, Toscano C, Andrus JK. Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean Value in Health Regional Issues. 1: 248-253. DOI: 10.1016/J.Vhri.2012.10.003 |
0.414 |
|
| 2012 |
Castañeda-Orjuela C, Pastor D, Valdes W, Resch S, Toscano C, De la Hoz-Restrepo F. PRM12 Comparison of Two Approaches to Costing National Immunization Programs: Central Level Budgeting Versus Detailing Costing Exercises Using a Novel Provac EPI Costing Tool in Bolivia Value in Health. 15: A161. DOI: 10.1016/J.Jval.2012.03.869 |
0.383 |
|
| 2012 |
Chen S, Toy M, Yeh J, Resch S, Wang J. PIN52 Cost-Effectiveness Analysis of Hepatitis B Control Program: Optimal Strategy for Different Prevalence Rates Value in Health. 15: A246. DOI: 10.1016/J.Jval.2012.03.1328 |
0.32 |
|
| 2011 |
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic returns to investment in AIDS treatment in low and middle income countries. Plos One. 6: e25310. PMID 21998648 DOI: 10.1371/Journal.Pone.0025310 |
0.458 |
|
| 2011 |
Lin JM, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, Simon CJ. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Effectiveness and Resource Allocation : C/E. 9: 1. PMID 21251294 DOI: 10.1186/1478-7547-9-1 |
0.348 |
|
| 2011 |
Jauregui B, Sinha A, Clark AD, Bolanos BM, Resch S, Toscano CM, Matus CR, Andrus JK. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine. 29: 1099-106. PMID 21144916 DOI: 10.1016/J.Vaccine.2010.11.075 |
0.34 |
|
| 2010 |
Semel ME, Resch S, Haynes AB, Funk LM, Bader A, Berry WR, Weiser TG, Gawande AA. Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitals. Health Affairs (Project Hope). 29: 1593-9. PMID 20820013 DOI: 10.1377/Hlthaff.2009.0709 |
0.308 |
|
| 2009 |
Regenbogen SE, Greenberg CC, Resch SC, Kollengode A, Cima RR, Zinner MJ, Gawande AA. Prevention of retained surgical sponges: a decision-analytic model predicting relative cost-effectiveness. Surgery. 145: 527-35. PMID 19375612 DOI: 10.1016/J.Surg.2009.01.011 |
0.35 |
|
| 2006 |
Salomon JA, Lloyd-Smith JO, Getz WM, Resch S, Sánchez MS, Porco TC, Borgdorff MW. Prospects for advancing tuberculosis control efforts through novel therapies. Plos Medicine. 3: e273. PMID 16866578 DOI: 10.1371/Journal.Pmed.0030273 |
0.313 |
|
| 2006 |
Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. Plos Medicine. 3: e241. PMID 16796403 DOI: 10.1371/Journal.Pmed.0030241 |
0.477 |
|
| 2005 |
Gebrekristos HT, Resch SC, Zuma K, Lurie MN. Estimating the impact of establishing family housing on the annual risk of HIV infection in South African mining communities. Sexually Transmitted Diseases. 32: 333-40. PMID 15912078 DOI: 10.1097/01.Olq.0000154496.61014.10 |
0.326 |
|
| 2005 |
Resch S, Altice FL, Paltiel AD. Cost-effectiveness of HIV screening for incarcerated pregnant women. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 163-73. PMID 15671801 DOI: 10.1097/01.Qai.0000146598.40301.E6 |
0.435 |
|
| Show low-probability matches. |